Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Bio-Techne Corp (TECH) had Revenue of $316.18M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$316.18M
Net Income	$22.59M
Cost of Goods Sold	$101.62M
Gross Profit	$214.56M
Operating Expenses	$277.47M
Operating Income	$38.71M
Non-Operating Income/Expense	$-0.43M
Pre-Tax Income	$38.27M
Normalized Pre-Tax Income	$38.27M
Income after Taxes	$22.59M
Income from Continuous Operations	$22.59M
Consolidated Net Income/Loss	$22.59M
Normalized Income after Taxes	$22.59M
EBIT	$38.71M
EBITDA	$66.28M
Weighted-Average Shares Outstanding (Basic)	157.37M
Weighted-Average Shares Outstanding (Diluted)	158.94M
Earnings per Share (EPS) (Basic)	$0.14
Earnings per Share (EPS) (Diluted)	$0.14
Balance Sheet Financials
Current Assets	$627.24M
Property, Plant, and Equipment	$251.98M
Long-Term Assets	$2.02B
Total Assets	$2.64B
Current Liabilities	$169.20M
Long-Term Debt	$330.00M
Long-Term Liabilities	$457.03M
Total Liabilities	$626.23M
Common Equity	$2.02B
Tangible Shareholders Equity	$605.71M
Shareholders Equity	$2.02B
Common Shares Outstanding	156.76M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$189.35M
Cash Flow from Investing Activities	$-35.59M
Cash Flow from Financial Activities	$-163.45M
Beginning Cash	$151.79M
End Cash	$140.67M
Increase/Decrease in Cash	$-11.12M
Stock-Based Compensation	$36.28M
Common Stock Dividends Paid	$-38.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.71
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.16
Gross Margin	67.86%
Operating Margin	12.24%
EBIT Margin	12.24%
EBITDA Margin	--
Pre-Tax Profit Margin	12.11%
Profit Margin	7.14%
Free Cash Flow	$163.24M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.53
Receiveable Turnover	1.33
Days Sales in Receivables	67.50
Return on Equity	1.12%
Return on Tangible Equity	3.73%
Return on Assets	0.85%
Return on Investments	0.96%
Book Value Per Share	$12.87
Free Cash Flow per Share	$1.03
Operating Cash Flow per Share	$1.19

Data from Zacks Investment Research, Inc.